Daratumumab in Combination With ATRA

Clinical trial NCT02751255 · COMPLETED

Trial details

NCT number: NCT02751255
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2016-07-06
Primary completion: 2022-10-18
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.